MAIA
MAIA Biotechnology, Inc. · Healthcare · Market cap $68.1M
Insiders bought $352K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Sep 15, 2026
Insider Buying
$996K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Sep 15, 2026
Vitoc Vlad
MAIA Biotechnology, Inc. (MAIA) has 22 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 7 insiders at MAIA Biotechnology, Inc. reported 26 open-market purchases totaling $996K and no open-market sales. The most active filer is Chief Executive Officer Vitoc Vlad with 7 filings. Insiders have net bought $556K over the trailing 6 months. The most recent open-market filing is a purchase of 73,000 shares by Chief Executive Officer Vitoc Vlad, dated Sep 14, 2026, worth $100K.
- Industry:Biotechnology
- CEO:Vlad Vitoc
- Employees:13
- HQ:Chicago, IL, US
- IPO:2022-07-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Vitoc VladFirst in 4 months | Chief Executive Officer | Purchase | 73,000 | $100K | Sep 15 | -16.4% | SEC ↗ |
| Director | Purchase | 37,595 | $50K | Sep 14 | -19.4% | SEC ↗ | |
| Director | Purchase | 8,931 | $12K | Sep 1 | -13.8% | SEC ↗ | |
| Director | Purchase | 78,239 | $109K | Sep 1 | -13.8% | SEC ↗ | |
| Director | Purchase | 46,620 | $63K | Sep 1 | -13.8% | SEC ↗ | |
| Director | Purchase | 1,794 | $2K | Aug 26 | -19.4% | SEC ↗ | |
Guerrero RamiroFirst filing | Director | Purchase | 11,899 | $16K | Aug 24 | -17.0% | SEC ↗ |
Gryaznov SergeiFirst filing | Chief Scientific Officer | Purchase | 2,000 | $3K | Jun 2 | -17.0% | SEC ↗ |
Vitoc VladFirst in 6 months | Chief Executive Officer | Purchase | 72,700 | $101K | Jun 2 | -17.0% | SEC ↗ |
Smith StanFirst in 5 months | Director | Purchase | 75,000 | $100K | Jun 2 | -17.0% | SEC ↗ |
| Director | Purchase | 2,700 | $10K | Jan 12 | — | SEC ↗ | |
| Director | Purchase | 40,849 | $50K | Dec 23 | — | SEC ↗ | |
Louie Ngar YeeFirst filing | Director | Purchase | 81,699 | $100K | Dec 23 | — | SEC ↗ |
| Director | Purchase | 57,189 | $70K | Dec 23 | — | SEC ↗ | |
| Director | Purchase | 13,740 | $16K | Dec 9 | — | SEC ↗ | |
| Chief Executive Officer | Purchase | 22,000 | $23K | Dec 4 | — | SEC ↗ | |
| Chief Executive Officer | Purchase | 50,000 | $57K | Dec 4 | — | SEC ↗ | |
| Chief Executive Officer | Purchase | 10,500 | $10K | Dec 4 | — | SEC ↗ | |
| Director | Purchase | 20,000 | $22K | Dec 1 | — | SEC ↗ | |
| Director | Purchase | 18,145 | $20K | Dec 1 | — | SEC ↗ | |
| Director | Purchase | 15,000 | $16K | Dec 1 | — | SEC ↗ | |
Luput CristianFirst filing | Director | Purchase | 10,000 | $10K | Nov 28 | — | SEC ↗ |
Smith StanFirst filing | Director | Purchase | 10,000 | $10K | Nov 26 | — | SEC ↗ |
Smith StanFirst filing | Director | Purchase | 15,000 | $15K | Nov 26 | — | SEC ↗ |
Vitoc VladFirst filing | Chief Executive Officer | Purchase | 1,800 | $2K | Nov 25 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does MAIA have?
MAIA Biotechnology, Inc. (MAIA) has 22 SEC Form 4 filings (32 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for MAIA?
The most recent Form 4 filing for MAIA on Tracefour is dated Sep 15, 2026.
Who is the most active insider at MAIA?
The most active SEC Form 4 filer at MAIA in the rolling window is Chief Executive Officer Vitoc Vlad, with 7 filings.
What is the net insider flow at MAIA over the last 6 months?
Over the trailing 180 days, insiders at MAIA have net bought $556K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MAIA in the current window?
Inside the rolling window, insiders at MAIA bought $996K and sold $0 based on SEC Form 4 filings.
Can I get alerts for MAIA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MAIA Biotechnology, Inc. (MAIA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
MAIA Biotechnology, Inc. is in the Healthcare sector.